Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 13
Item hits:
Issue DateTitleAuthor(s)
11-Dec-2018Evidence for a protective role for the rs805305 single nucleotide polymorphism of dimethylarginine dimethylaminohydrolase 2 (DDAH2) in septic shock through the regulation of DDAH activityLambden, S; Tomlinson, J; Piper, S; Gordon, AC; Leiper, J, et al
23-Feb-2017Levosimendan in Sepsis.Gordon, AC; Orme, RML; Singer, M; National Institute for Health Research; Tenax Therapeutics Inc
23-Feb-2017Levosimendan in Sepsis REPLYGordon, AC; Orme, RML; Singer, M; National Institute for Health Research; National Institute for Health Research, et al
5-Oct-2016Levosimendan for the prevention of acute organ dysfunction in sepsisGordon, AC; Perkins, GD; Singer, M; McAuley, DF; Orme, RML, et al
8-May-2018Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive ShockMcIntyre, WF; Um, KJ; Alhazzani, W; Lengyel, AP; Hajjar, L, et al
2-Aug-2016Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock. The VANISH Randomized Clinical TrialGordon, AC; Mason, AJ; Thirunavukkarasu, N; Perkins, GD; Cecconi, M, et al
13-Jul-2016Protocol for a randomised control trial of methylnaltrexone for the treatment of opioid-induced constipation and gastrointestinal stasis in intensive care patients (MOTION)Brett, SJ; O'Callaghan, D; Anjum, A; Cross, M; Warwick, J, et al
-Levosimendan for the Prevention of Acute oRgan Dysfunction in Sepsis: the LeoPARDS Randomised Controlled TrialGordon, AC; Santhakumaran, S; Al-Beidh, F; Orme, RML; Perkins, GD, et al
4-Jun-2018A global perspective on vasoactive agents in shockAnnane, D; Ouanes-Besbes, L; De Backer, D; Du, B; Gordon, AC, et al
Nov-2019Terlipressin or norepinephrine, or both in septic shock?MÃ¥rtensson, J; Gordon, AC; National Institute for Health Research; National Institute for Health Research